A. D. Beadell Investment Counsel, Inc. Zoetis Inc. Transaction History

A. D. Beadell Investment Counsel, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$155.9 - $187.99 $913,574 - $1.1 Million	-5,860 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$137.1 - $165.37 $426,381 - $514,300	3,110 Added 113.09%	5,860 $969,000
Q1 2020 Apr 22, 2020	BUY	$92.66 - $144.94 $23,165 - $36,235	250 Added 10.0%	2,750 $323,000
Q2 2018 Jul 19, 2018	SELL	$79.9 - $89.2 $39,950 - $44,600	-500 Reduced 16.67%	2,500 $212,000
Q1 2018 Apr 25, 2018	BUY	$71.51 - $84.69 $214,530 - $254,070	3,000 New	3,000 $250,000

1,860

416M

1.13M

1.81M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $81.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of A. D. Beadell Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on A. D. Beadell Investment Counsel, Inc. with notifications on news.